Description: CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
Home Page: www.cmgpharma.co.kr
Cheongdam-dong 18-20, #B01
Seoul,
135-949
South Korea
Phone:
82 3 1881 7600
Officers
| Name | Title |
|---|---|
| Jung-Gook Kim | Exec. |
| Joohyung Lee | Chief Exec. Officer |
| Tae-Rim Oh | Sr. Managing Director and Head of New Bus. Division |
| Joong-Hwan Bae | Head of Management Supporting Team and Director |
| B. J. Kim | Managing Director |
| Cheon-Woo Nam | Exec. |
| Hyun-Sun Yeom | Exec. |
| Young-Gon Yoon | Exec. |
| Sun-Won Lee | Exec. |
| Sun-Baek Bang | Exec. |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.0714 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |